Other News To Note
Resverlogix Corp., of Calgary, Alberta, said its board approved a proposal to spin out its subsidiary, RVX Therapeutics Inc., which will focus on drug research and development by leveraging its epigenetics platform.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter